Wnt1 is anti-lymphangiogenic in a melanoma mouse model

Journal of Investigative Dermatology

Volumn 132, Issue 9, 2012, Pages 2235-2244

  Niederleithner, Heide ^a   Heinz, Magdalena ^a   Tauber, Stefanie ^a,b   Bilban, Martin ^c   Pehamberger, Hubert ^c   Sonderegger, Stefan ^d   Knöfler, Martin ^c   Bracher, Andreas ^a   Berger, Walter ^e   Loewe, Robert ^a,c   Petzelbauer, Peter ^a,c  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MONASH UNIVERSITY   (Australia)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOSPORIN A; GLYCOGEN SYNTHASE KINASE 3BETA; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN C; WNT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHANGIOGENESIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE METASTASIS; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84865320904     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.138     Document Type: Article

References (48)

1. Bachmann IM, Straume O, Puntervoll HE et al. (2005) Importance of Pcadherin, beta-catenin, and WNT5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 11:8606-14
2. Beurel E, Jope RS (2009) Glycogen synthase kinase-3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264.7 cells. Cell Signal 21:978-85
3. Boone B, Blokx W, De BD et al. (2008) The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch 453:257-65
4. Brabletz T, Jung A, Dag S et al. (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155:1033-8
5. Chien AJ, Moore EC, Lonsdorf AS et al. (2009) Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 106:1193-8
6. Da Forno PD, Pringle JH, Hutchinson P et al. (2008) WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 14:5825-32
7. Dadras SS, Lange-Asschenfeldt B, Velasco P et al. (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18:1232-42
8. Dadras SS, Paul T, Bertoncini J et al. (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951-60
9. Damsky WE, Curley DP, Santhanakrishnan M et al. (2011) beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20:741-54
10. Eichhoff OM, Weeraratna A, Zipser MC et al. (2011) Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell Melanoma Res 24:631-42
11. Fuerer C, Nusse R, Ten Berge D (2008) Wnt signalling in development and disease. Max Delbruck Center for Molecular Medicine meeting on Wnt signaling in Development and Disease. EMBO Rep 9:134-8
12. Gardner EJ (1962) Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am J Hum Genet 14:376-90
13. Goodwin AM, Kitajewski J, D'Amore PA (2007) Wnt1 and WNT5a affect endothelial proliferation and capillary length; Wnt2 does not. Growth Factors 25:25-32
14. Goydos JS, Gorski DH (2003) Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Cancer Res 9:5962-7
15. Groden J, Thliveris A, Samowitz W et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
16. Gröger M, Niederleithner H, Kerjaschki D et al. (2007) A previously unknown dermal blood vessel phenotype in skin inflammation. J Invest Dermatol 127:2893-900
17. He Y, Rajantie I, Ilmonen M et al. (2004) Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64:3737-40
18. Hiendlmeyer E, Regus S, Wassermann S et al. (2004) Beta-catenin upregulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res 64:1209-14
19. Hoshida T, Isaka N, Hagendoorn J et al. (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66:8065-75
20. Ishikawa T, Tamai Y, Zorn AM et al. (2001) Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 128: 25-33
21. Kageshita T, Hamby CV, Ishihara T et al. (2001) Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 145:210-6
22. Khramtsov AI, Khramtsova GF, Tretiakova M et al. (2010) Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 176:2911-20
23. Kielhorn E, Provost E, Olsen D et al. (2003) Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer 103:652-6
24. Kim TH, Xiong H, Zhang Z et al. (2005) beta-Catenin activates the growth factor endothelin-1 in colon cancer cells. Oncogene 24:597-604
25. Korff T, Augustin HG (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci 112(Part 19):3249-58
26. Loewe R, Valero T, Kremling S et al. (2006) Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res 66:11888-96
27. Lohela M, Bry M, Tammela T et al. (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154-65
28. Masckauchan TN, Shawber CJ, Funahashi Y et al. (2005) Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 8:43-51
29. Metzner T, Bedeir A, Held G et al. (2011) Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition. J Invest Dermatol 131:2087-95
30. Mikels AJ, Nusse R (2006) Purified WNT5a protein activates or inhibits betacatenin- TCF signaling depending on receptor context. PLoS Biol 4:e115
31. Monkley SJ, Delaney SJ, Pennisi DJ et al. (1996) Targeted disruption of the Wnt2 gene results in placentation defects. Development 122: 3343-53
32. Mueller BM, Romerdahl CA, Trent JM et al. (1991) Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res 51:2193-8
33. Orlandini M, Semboloni S, Oliviero S (2003) Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem 278:44650-6
34. Rinderknecht M, Detmar M (2008) Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol 216:347-54
35. Ryeom S, Baek KH, Rioth MJ et al. (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13:420-31
36. Salven P, Lymboussaki A, Heikkila P et al. (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153:103-8
37. Samarzija I, Sini P, Schlange T et al. (2009) Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun 386:449-54
38. Schietroma C, Cianfarani F, Lacal PM et al. (2003) Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 98:789-97
39. Shimokawa T, Furukawa Y, Sakai M et al. (2003) Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res 63:6116-20
40. Shu W, Jiang YQ, Lu MM et al. (2002) Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 129: 4831-42
41. Sinnberg T, Menzel M, Ewerth D et al. (2011) beta-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One 6:e23429
42. Skobe M, Hamberg LM, Hawighorst T et al. (2001) Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 159:893-903
43. Spinsanti P, De Vita T, Caruso A et al. (2008) Differential activation of the calcium/protein kinase C and the canonical beta-catenin pathway by Wnt1 and Wnt7a produces opposite effects on cell proliferation in PC12 cells. J Neurochem 104:1588-98
44. Staal FJ, Luis TC, Tiemessen MM (2008) WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 8:581-93
45. Takahashi Y, Nishikawa M, Suehara T et al. (2008) Gene silencing of betacatenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice. Int J Cancer 123:2315-20
46. Widlund HR, Horstmann MA, Price ER et al. (2002) Beta-catenin-induced melanoma growth requires the downstream target Microphthalmiaassociated transcription factor. J Cell Biol 158:1079-87
47. Wright M, Aikawa M, Szeto W et al. (1999) Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem Biophys Res Commun 263:384-8
48. Zerlin M, Julius MA, Kitajewski J (2008) Wnt/Frizzled signaling in angiogenesis. Angiogenesis 11:63-9